Behnia Akbari
Overview
Explore the profile of Behnia Akbari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
90
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mohamed Khosroshahi L, Zabihi M, Akbari B, Hadjati J, Noorbakhsh F
Iran J Allergy Asthma Immunol
. 2025 Mar;
24(1):61-70.
PMID: 40052890
Circular RNAs (circRNAs) are endogenous non-coding RNA molecules that form covalently closed molecular loops. By regulating gene expression, circRNAs are known to play crucial roles in the development and progression...
2.
Hosseini M, Akbari B, Shahverdi A, Hadjati J, Faramarzi M, Mirzaei H, et al.
Curr Protoc
. 2024 Aug;
4(8):e1107.
PMID: 39166803
CAR-T cell therapy has emerged as a potent and effective tool in the immunotherapy of refractory cancers. However, challenges exist in their clinical application, necessitating extensive preclinical research to optimize...
3.
Soltantoyeh T, Akbari B, Shahosseini Z, Mirzaei H, Hadjati J
Front Immunol
. 2024 Jun;
15:1362904.
PMID: 38855110
Introduction: Chimeric antigen receptor (CAR) T cell therapy has transformed the treatment of hematological malignancies. However, its efficacy in solid tumors is limited by the immunosuppressive tumor microenvironment that compromises...
4.
Panahi Meymandi A, Akbari B, Soltantoyeh T, Shahosseini Z, Hosseini M, Hadjati J, et al.
Front Oncol
. 2024 Mar;
14:1357801.
PMID: 38425341
Introduction: Chimeric Antigen Receptor (CAR) T cell therapy has demonstrated remarkable success in treating hematological malignancies. However, its efficacy against solid tumors, including cervical cancer, remains a challenge. Hypoxia, a...
5.
Ghaffari S, Saleh M, Akbari B, Ramezani F, Mirzaei H
Immunology
. 2023 Nov;
171(3):339-364.
PMID: 38009707
Chimeric antigen receptor (CAR) T cell therapy is a promising cancer treatment modality. The breakthroughs in CAR T cell therapy were, in part, possible with the help of cell analysis...
6.
Akbari B, Ahmadi E, Zabihi M, Zamir M, Sadeghi Shaker M, Noorbakhsh F
BMC Genom Data
. 2023 Nov;
24(1):68.
PMID: 37980504
Background: Viruses employ diverse strategies to interfere with host defense mechanisms, including the production of proteins that mimic or resemble host proteins. This study aimed to analyze the similarities between...
7.
Ramezani F, Panahi Meymandi A, Akbari B, Tamtaji O, Mirzaei H, Brown C, et al.
Mol Cancer
. 2023 Nov;
22(1):183.
PMID: 37974170
Chimeric antigen receptor (CAR) NK and T cell therapy are promising immunotherapeutic approaches for the treatment of cancer. However, the efficacy of CAR NK/T cell therapy is often hindered by...
8.
Panahi Meymandi A, Akbari B, Soltantoyeh T, Hadjati J, Klionsky D, Badie B, et al.
Front Immunol
. 2023 Sep;
14:1212695.
PMID: 37675121
Despite chimeric antigen receptor (CAR) T cell therapy's extraordinary success in subsets of B-cell lymphoma and leukemia, various barriers restrict its application in solid tumors. This has prompted investigating new...
9.
Akbari B, Soltantoyeh T, Shahosseini Z, Jadidi-Niaragh F, Hadjati J, Brown C, et al.
Front Immunol
. 2023 Jul;
14:1209572.
PMID: 37457723
Introduction: For many years, surgery, adjuvant and combination chemotherapy have been the cornerstone of pancreatic cancer treatment. Although these approaches have improved patient survival, relapse remains a common occurrence, necessitating...
10.
Akbari B, Soltantoyeh T, Shahosseini Z, Yarandi F, Hadjati J, Mirzaei H
Cancer Cell Int
. 2023 May;
23(1):104.
PMID: 37244991
Background: Chemotherapy and surgery have been the mainstays of epithelial ovarian cancer (EOC) treatment so far. Cellular immunotherapies such as CAR T cell therapy have recently given hope of a...